The Consolidated Appropriations Act of 2023 (Omnibus) amended the Federal Food, Drug, and Cosmetic Act to require medical device manufacturers to address cybersecurity. As of March 29, 2023, they must provide cybersecurity details in premarket submissions. The Omnibus mandates plans for postmarket cybersecurity vulnerabilities, device cybersecurity demonstrations, and software bill of materials (SBOM) disclosures. Starting October 1, 2023, the FDA will reject submissions not meeting cybersecurity criteria, emphasizing proactive cybersecurity measures.
Malware-infected apps found on Apple’s App Store, targeting crypto wallets
Cybersecurity firm Kaspersky reports that malware harvesting information from screenshots has emerged on Apple’s App Store for the first time. The “SparkCat” malware uses Optical
